Harvard Bioscience (HBIO) Change in Account Payables (2016 - 2020)
Harvard Bioscience (HBIO) has disclosed Change in Account Payables for 11 consecutive years, with -$154000.0 as the latest value for Q4 2020.
- Quarterly Change in Account Payables fell 1500.0% to -$154000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $511000.0 through Dec 2020, up 124.95% year-over-year, with the annual reading at $511000.0 for FY2020, 124.95% up from the prior year.
- Change in Account Payables for Q4 2020 was -$154000.0 at Harvard Bioscience, up from -$585000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $2.0 million in Q4 2018, with the low at -$2.7 million in Q1 2016.
- Average Change in Account Payables over 5 years is -$163750.0, with a median of -$125000.0 recorded in 2017.
- Peak annual rise in Change in Account Payables hit 1641.67% in 2018, while the deepest fall reached 2598.8% in 2018.
- Over 5 years, Change in Account Payables stood at $372000.0 in 2016, then crashed by 135.48% to -$132000.0 in 2017, then surged by 1641.67% to $2.0 million in 2018, then crashed by 99.46% to $11000.0 in 2019, then tumbled by 1500.0% to -$154000.0 in 2020.
- According to Business Quant data, Change in Account Payables over the past three periods came in at -$154000.0, -$585000.0, and -$72000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.